Femasys (FEMY) Other Non-Current Liabilities (2020 - 2026)
Femasys (FEMY) reported Other Non-Current Liabilities of $5.2 million for Q1 2026, up 182.05% on a YoY basis from $1.9 million in Q1 2025, and up 6.13% quarter-over-quarter from $4.9 million in Q4 2025.
Femasys (FEMY) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Femasys has reported Other Non-Current Liabilities for 7 years, with the latest figure at $5.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 182.05% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (up 182.05% YoY), and the FY2025 full-year result was $4.9 million, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $5.2 million, up from $4.9 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $6.7 million in Q3 2025, with the low at $567972.0 in Q2 2022.
- Historically, Other Non-Current Liabilities has averaged $2.4 million across 5 years, with a median of $1.9 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 1626.62% — and 2025, when it plunged 30.17%.
- Femasys' Other Non-Current Liabilities stood at $567972.0 in 2022, then soared by 390.72% to $2.8 million in 2023, then fell by 6.4% to $2.6 million in 2024, then soared by 89.49% to $4.9 million in 2025, then advanced by 6.13% to $5.2 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $5.2 million (Q1 2026), $4.9 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 567,972.00 |
| Dec 31, 2022 | 567,972.00 |
| Sep 30, 2022 | 567,972.00 |
| Jun 30, 2022 | 567,972.00 |
| Mar 31, 2022 | 702,492.00 |
| Dec 31, 2021 | 702,492.00 |
| Sep 30, 2021 | 32,895.00 |
| Jun 30, 2021 | 32,895.00 |
| Dec 31, 2020 | 702,492.00 |